Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTLA
NTLA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTLA News
Intellia Therapeutics Overcomes Regulatory Setback
Mar 08 2026
NASDAQ.COM
Analysis of Intellia Therapeutics' Stock Price Recovery
Mar 08 2026
Fool
Cathie Wood's Intellia Therapeutics Surges 47%: Is It Too Late to Invest?
Mar 08 2026
Yahoo Finance
Wall Street Analysts Adjust Ratings
Mar 04 2026
Benzinga
Cathie Wood Continues to Add to Growth Stock Positions
Mar 03 2026
Fool
Wall Street Analysts Adjust GE Stock Ratings
Mar 03 2026
Benzinga
Intellia Presents New Research at AAAAI Meeting
Mar 03 2026
Newsfilter
Intellia Therapeutics FDA Lifts Clinical Hold on Nexizuran Trials
Mar 02 2026
seekingalpha
Intellia Therapeutics Receives FDA Approval for Clinical Trial
Mar 02 2026
Benzinga
INTELLIA THERAPEUTICS STOCK RISES 2% FOLLOWING US FDA'S LIFTING OF CLINICAL HOLD ON HEART DISEASE GENE THERAPY TRIAL
Mar 02 2026
moomoo
Intellia's Shares Jump as FDA Lifts Hold on Nexiguran Trial
Mar 02 2026
stocktwits
Intellia Receives FDA Lift on Clinical Hold for Nex-z Trials
Mar 02 2026
Newsfilter
Intellia Therapeutics Q4 2025 Earnings Call Insights
Feb 27 2026
seekingalpha
Intellia (NTLA) Q4 2025 Earnings Call Transcript
Feb 26 2026
NASDAQ.COM
Intellia Therapeutics Q4 Earnings Beat Expectations
Feb 26 2026
seekingalpha
Intellia Reports 2025 Financials and Clinical Progress Updates
Feb 26 2026
Newsfilter
Show More News
